Filter
3003
Filtered Results: 3003
Text search:
laboratórios
Featured
Recommendations
293
New Publications
794
Language
Document type
No document type
1594
Guidelines
519
Studies & Reports
406
Strategic & Response Plan
192
Manuals
148
Fact sheets
48
Situation Updates
42
Training Material
34
Brochures
6
Resource Platforms
6
Infographics
5
Videos
2
Online Courses
1
Countries / Regions
India
142
Congo, Democratic Republic of
83
Latin America and the Carribbean
78
Sierra Leone
72
Global
69
Africa
65
Liberia
64
Western and Central Europe
63
Kenya
62
Senegal
58
Nigeria
54
South Africa
49
Guinea
47
Ethiopia
46
Burkina Faso
45
Paraguay
42
Uganda
41
Colombia
40
Rwanda
36
Ghana
34
Venezuela
34
Eastern Europe
34
Nepal
33
West and Central Africa
33
Argentina
31
Tanzania
30
Bangladesh
29
Peru
29
Bolivia
29
Haiti
28
Cameroon
27
Malawi
27
Benin
27
East and Southern Africa
27
Syria
24
Mali
23
Zambia
22
Madagascar
20
Philippines
19
South–East Asia Region
19
Brazil
18
Mozambique
17
Namibia
17
Ukraine
17
Myanmar / Burma
17
Zimbabwe
16
El Salvador
16
Côte d’Ivoire / Ivory Coast
15
Cambodia
15
Ecuador
14
Middle East and North Africa
14
Chile
13
Niger
12
Russia
12
Togo
11
Spain
11
Pakistan
10
Yemen
10
Eswatini/ Swaziland
9
Botswana
9
Germany
8
Central African Republic
8
France
8
USA
7
Lesotho
7
Western Pacific Region
7
Afghanistan
6
Chad
6
Indonesia
6
Asia
6
South Sudan
5
Thailand
5
Honduras
5
Angola
5
Eastern Europe and Central Asia
5
Albania
5
Georgia
5
Guinea-Bissau
4
Morocco
4
Somalia
4
Iraq
4
Moldova
4
Vietnam
4
Saudi Arabia
3
Lebanon
3
Turkey
3
Sudan
3
Dominican Republic
3
Burundi
3
Guatemala
3
Mexico
3
Laos
3
Congo-Brazzaville
3
Uruguay
3
Jordan
2
China
2
North Macedonia
2
Greece
2
Libya
2
Nicaragua
2
Sri Lanka
2
Armenia
2
Southern Africa
2
Canada
2
Timor Leste/ East Timor
2
Tajikistan
2
Iran
2
North America
2
Gabon
2
Mauritius
2
Tunisia
2
Portugal
2
Gambia
1
Malaysia
1
Mauritania
1
Ireland
1
Papua New Guinea
1
Serbia
1
Hungary
1
Cuba
1
Other region
1
Luxembourg
1
Bhutan
1
Poland
1
Palestine
1
Italy
1
Djibouti
1
Qatar
1
Bulgaria
1
Estonia
1
Romania
1
Slovakia
1
Australia
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
1298
Clinical Guidelines
231
Pharmacy & Technologies
114
Public Health
104
Key Resources
104
Women & Child Health
51
Capacity Building
20
Toolboxes
COVID-19
387
TB
354
Rapid Response
228
AMR
208
HIV
180
Ebola
155
NTDs
89
Pharmacy
72
Planetary Health
53
Mental Health
52
Zika
46
Polio
38
Caregiver
36
Cholera
34
Conflict
32
Natural Hazards
24
Refugee
24
Specific Hazards
24
Disability
20
Health Financing Toolbox
15
NCDs
14
Global Health Education
11
Social Ethics
6
Health Financing
1
This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic mod...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
The annual Development Co-operation Report brings new evidence, analysis and ideas on
sustainable development to members of the OECD Development Assistance Committee (DAC) and the international community more broadly. The objectives are to promote best practices and innovation in development co-ope...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Cholera is an acute gastrointestinal infection caused by the bacterium Vibrio Cholerae serogroup O1 or O139, and is often linked to unsafe drinking water, lack of proper sanitation and personal hygiene. It adversely affects mostly the poor and vulnerable populations in countries, which are already d...
The ERF provides WHO staff with essential guidance on how the Organization manages the assessment, grading and response to public health events and emergencies with health consequences, in support of Member States and affected communities. The ERF adopts an all-hazards approach and it is therefore a...
Through technical consultations with countries and partners, WHO has led the development of Preparedness and Resilience for Emerging Threats Module 1: Planning for respiratory pathogen pandemics. Version 1.0. The Module, currently available as an advanced draft, builds on previous pandemic lessons a...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Diabetes mellitus is a major cause of morbidity and mortality in Scotland and worldwide, with an increasing prevalence. In 2009 there were around 228,000 people registered as having diabetes in Scotland, an increase of 3.6% from the preceding year. This increase relates, in part, to the increasing a...
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the prevention and control of hypertension and diabetes, identifying the most impactful NCD interventions within their context, closing the gaps in ca...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
